Prevas

* Margin improvement in Q3* We raise '26e-'27e adj. EBITA by 4-3%* Trading ~30% below current peers on '26e-'27e EV/EBITACost-cutting starting to take effectPrevas' Q3 report was better than we expected, with a 1% sales beat of SEK 355m (351m vs. ABGSCe...

* Sales +1% and adj. EBITA +29% vs ABGSCe* Strong within defence and cybersecurity* Consensus EBITA likely down up mid single-digitsQ3'25 detailsPrevas reports Q3'25 sales of SEK 355m (1% vs. ABGSCe 351m), and organic growth of -1%, with a notable contribution...

* Seasonally weak quarter* We cut '25e-'27e adj. EBITA by 2%Trading ~20% below current peers on '25e EV/EBITA Q3: Built for the long term Prevas will release its Q3'25 report on 24 October. We expect sales of SEK 351m, flat y-o-y growth, reflecting seasonal...

Q2 results Prevas reported a weaker-than-expected Q2'25, with sales of SEK 409m, up 3% y-o-y (4% below ABGSCe). Organic sales declined 9% y-o-y, driven by a drop in FTEs (a net reduction of 20 employees), lower utilisation, and a negative calendar effect...

Q2'25 details Prevas reports Q2'25 sales of SEK 409m (-4% vs. ABGSCe 428m), and an organic decline of 9%. Reported adj. EBITA came in at SEK 21m (-27% vs. ABGSCe 28m), with an adj. EBITA margin of 5%, affected by a lower utilisation rate, restructuring...

Q2 expectations Prevas will release its Q2'25 report on 17 July, and we expect SEK 428m in sales, implying y-o-y growth of 8%. However, this includes an organic decline of 4%, which is driven by a drop in organic FTEs, negative calendar effects and impacts...

6% organic sales decline y-o-y Enmac shows progress with good order intake Adj. EBITA down 13-7% for '25e-'26e Q1: High uncertainty is delaying investment decisions Prevas' Q1 report showed that the uncertain market situation continues to impact the ...